Pfizer Backs EU Manufacturing With €2.4bn Investment
Ireland And Belgium To Benefit
Executive Summary
Pfizer is betting big on its manufacturing plans in Europe, investing €1.2bn at respective sites in Ireland and Belgium to prepare for a number of launches it has lined up in the short term.